In this study, we combine gene sequencing with long amplicon ddPCR assays to integrate information about TP53 transcript abundance, TP53 mutation status and clinical and pathological information in cohort of tumors from 89 breast cancer patients. The gene discussed is TP53; the disease is breast cancer.